Personal information

No personal information available

Activities

Employment (1)

St. Joseph’s medical center: Stockton, CA, US

2022-06 to present | Urology resident (Urology)
Employment
Source: Self-asserted source
Gabrielle DiFiore

Education and qualifications (1)

NYIT: Jonesboro, AR, US

DO
Education
Source: Self-asserted source
Gabrielle DiFiore

Works (23)

Data from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Data from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Tables 1-8 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Tables 1-8 from Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction

2024-09-16 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Data from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-09-15 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

Clinical Cancer Research
2023-09-15 | Journal article
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-09-15 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-09-15 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-09-15 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-09-15 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Tables 1-8 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-09-15 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Tables 1-8 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-09-15 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Data from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-08-08 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-08-08 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-08-08 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-08-08 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Figure 2 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-08-08 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Tables 1-8 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-08-08 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref

Supplementary Tables 1-8 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction

2023-08-08 | Preprint
Contributors: Keyan Salari; Debasish Sundi; Jason J. Lee; Shulin Wu; Chin-Lee Wu; Gabrielle DiFiore; Q. Robert Yan; Andrew Pienkny; Chi K. Lee; Daniel Oberlin et al.
Source: check_circle
Crossref